Applied Therapeutics Growth Metrics (2023-2025) | APLT

Growth Metrics Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025
Growth Ratios
EBITDA Margin Growth (1y) -1.04M2.27M
EBITDA Margin (QoQ) -1.37M-0.36M-1.02M
EBIT Margin Growth (1y) -1.04M2.27M
EBIT Margin (QoQ) -1.37M-0.36M-1.02M
EBT Margin Growth (1y) -1.02M2.16M
EBT Margin (QoQ) -1.34M-0.35M-0.95M
Enterprise Value Growth (1y) -539.26%-243.10%-163.73%-59.12%65.32%75.11%87.92%
Enterprise Value (QoQ) -55.41%-5.29%-33.06%-193.60%16.59%19.07%19.72%36.02%40.12%60.73%
FCF Margin Growth (1y) -0.94M1.73M
FCF Margin (QoQ) -1.20M-0.62M-0.34M
Net Margin Growth (1y) -4.19M2.16M
Net Margin (QoQ) -4.76M2.82M-0.95M
Operating Margin Growth (1y) -1.04M2.27M
Operating Margin (QoQ) -1.37M-0.36M-1.02M
Return on Assets Growth (1y) 22.00-76.00-175.00-192.00
Return on Assets (QoQ) 55.0016.00-22.00-28.00-42.00-83.00-39.00
Return on Capital Employed Growth (1y) -455.00189.00-286.00-0.00M
Return on Capital Employed (QoQ) -696.00298.00-414.00356.00-52.00-177.00-0.00M
Return on Equity Growth (1y) -769.0067.00-291.00-913.00
Return on Equity (QoQ) -739.00182.00-119.00-92.0096.00-175.00-742.00
Return on Sales Growth (1y) -0.01M-0.02M-0.03M-0.07M0.02M
Return on Sales (QoQ) -0.01M-0.00M-0.01M0.00M-0.02M-0.05M0.09M